{
    "eid": "2-s2.0-85059494136",
    "title": "Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Analytical Chemistry",
            "@code": "1602",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Complementary and Alternative Medicine",
            "@code": "2707",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "apoptosis",
        "cell cycle arrest",
        "cepharanthine",
        "cytotoxicity",
        "Menispermaceae",
        "ovarian cancer",
        "Stephania cephalantha"
    ],
    "authors": [
        "Vilawan Payon",
        "Chanaporn Kongsaden",
        "Wannarasmi Ketchart",
        "Apiwat Mutirangura",
        "Piyanuch Wonganan"
    ],
    "citedby-count": 18,
    "ref-count": 33,
    "ref-list": [
        "Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction",
        "Ovarian cancer",
        "The pharmacological costs of second-line treatments for recurrent ovarian cancer",
        "Optimizing treatment in recurrent epithelial ovarian cancer",
        "The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: Implications for cancer, shock, and inflammatory diseases",
        "Ethnobotany, phytochemistry and pharmacology of Stephania rotunda Lour",
        "Antioxidant activity of bisbenzylisoquinoline alkaloids from Stephania rotunda: Cepharanthine and fangchinoline",
        "Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions",
        "Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models",
        "Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines",
        "Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1",
        "Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt",
        "Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid",
        "Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB",
        "Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells",
        "Inhibition of signal transducer and activator of transcription 3 and cyclooxygenase-2 is involved in radiosensitization of cepharanthine in HeLa cells",
        "Mechanisms and in vitro effects of cepharanthine hydrochloride: Classification analysis of the drug-induced differentially-expressed genes of human nasopharyngeal carcinoma cells",
        "Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells",
        "Characteristics of antitumour activity of cepharanthin against a human adenosquamous cell carcinoma cell line",
        "Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1",
        "Tumor suppressor genes associated with drug resistance in ovarian cancer (review)",
        "Oncogenes associated with drug resistance in ovarian cancer",
        "Ovarian cancer cell line panel (OCCP): Clinical importance of in vitro morphological subtypes",
        "The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer",
        "The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer",
        "Cyclin e as a potential therapeutic target in high grade serous ovarian cancer",
        "Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer",
        "Cyclin D1 predicts the prognosis of advanced serous ovarian cancer",
        "Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer",
        "Cell cycle and apoptosis",
        "Apoptosis - The p53 network",
        "Apoptosis assays with lymphoma cell lines: Problems and pitfalls",
        "The BCL-2 protein family: Opposing activities that mediate cell death"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Thailand Research Fund"
    ]
}